We have previously established a model inducing hematopoietic stem cell (HSC) production of circulating endothelial progenitor cells (EPC) to revascularize ischemic injury in adult mouse retina. The unique vascular environment of the retina results in new blood vessel formation primarily from HSC-derived EPC.
Abstract
We have previously established a model inducing hematopoietic stem cell (HSC) production of circulating endothelial progenitor cells (EPC) to revascularize ischemic injury in adult mouse retina. The unique vascular environment of the retina results in new blood vessel formation primarily from HSC-derived EPC.
Using inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) deficient (-/-) mice, we show that vessel phenotype resulting from hemangioblast activity can be altered by modulation of the nitric oxide/nitric oxide synthase pathway. iNOS -/-or eNOS -/-animals were engrafted with wild type (WT)
HSC expressing green fluorescence protein (gfp + ) and subjected to our adult retinal ischemia model. WT hemangioblast activity in adult iNOS -/-recipients resulted in the formation of highly branched blood vessels of donor origin which were readily perfused indicating functionality. In contrast, eNOS -/-recipients produced relatively unbranched blood vessels with significant donor contribution that were difficult to perfuse indicating poor functionality. Furthermore, eNOS -/-chimeras had extensive gfp + HSC contribution throughout their vasculature without additional injury. This neovascularization, via EPC derived from the transplanted HSC, reveals that the NO pathway can modulate EPC activity and plays a critical role in both blood vessel formation in response to injury and normal endothelial cell maintenance.
Introduction
During embryogenesis, the hematopoietic and endothelial lineages arise from a common progenitor termed the hemangioblast. 1 We recently demonstrated that hemangioblast activity persists into adulthood by showing that adult HSC produce both blood and blood vessels. 2 In adults, the relatively short lifespan of most blood cells necessitates replacement in large quantities each day to maintain homeostasis. Conversely, the endothelial vasculature in the eye can have up to a four-year half-life in humans. When these vessels are replaced it has been traditionally believed that the new EC were derived solely from local EC proliferation. However, both EC and EPC were found in the circulation posing the question whether cells of the vasculature can be formed from remote sources. 3, 4 Multiple studies demonstrate the bone marrow origin of EPC in a variety of ischemic and wound repair models. [5] [6] [7] [8] In these models new vessel formation appears to be a combination of EC and EPC contributions, with EC forming the majority of each new vessel. In contrast, ischemia or injury alone is not sufficient to induce neovascularization of the adult murine retina. Induction of retinal neovascularization requires both exogenous administration of vascular endothelial growth factor (VEGF) and ischemic injury. Providing both stimuli resulted in a highly proliferative retinopathy including new vessels protruding into We found that the NO pathway is a significant regulator of neovascularization and can modulate hemangioblast activity by dictating the size and branching characteristics of blood vessels formed in response to ischemic or chronic injury.
Our model provides a unique method of preferentially inducing EPC driven repair of ischemic injury in the eye. The NO pathway has also been shown to affect blood cell proliferation, migration, and mobilization. 13, 16, 17 The overlapping effects of the NO pathway in both blood and blood vessel formation further highlights the developmental relationship of the vascular and hematopoietic systems. 
Methods

Generation of eNOS and iNOS
Detection and localization of NOS produced in NOS deficient animals.
To compare the amount of NO produced by the various isoform knockouts, iNOS and eNOS specific antibodies (Pharmingen, San Jose, CA) were used to test levels seen under normal conditions and in situations when a specific isoform is missing. C57BL/6, iNOS -/-and eNOS -/-animals were quantitated for NOS expression in parallel. Animals were sacrificed and the eyes enucleated as described above except these animals were not perfused with the TRITC/PFA 20 This sickliness is exacerbated with bone marrow ablation such as irradiation such as shown by diminished HSC proliferation. 13 Consequently, eNOS cohorts received a minimum of 2500 highly enriched HSC to ensure robust donor engraftment due to the reduced radiation level tolerated by the knockout animals.
All cohorts compared were age matched and exhibited matched percentages of donor engraftment levels prior to ischemic model, and recipients which were robustly reconstituted by donor HSC (>70% donor derived myeloid cells as the benchmark) subsequently underwent our model of ischemic injury to induce adult retinal neovascularization (n > 10 for all cohorts). Peripheral blood from a typical BL6 (Fig. 1 , top row) and gfp + (Fig. 1 , second row) mouse are shown as a reference for comparison of the engraftment levels of the test animals. The enriched HSC populations used for transplantation into the NOS deficient mice were isolated using the same protocol previously employed for single cell transplants in BL6 animals ( Fig. 1, third row) . 2 ). To demonstrate that HSC derived EPC are present in the circulation and available for contribution to neovascularization, peripheral blood was drawn and analyzed for donor EPC. Both irradiated and treated animals and untreated animals had significant amounts (>10%) of circulating EPC contained in the nucleated blood cells (Fig.1 bottom row) . We found slightly increased levels of circulating gfp + EPC in the experimental animals which could hint that irradiation, VEGF, and ischemic injury are signaling for increased BM EPC production (unpublished observation). This phenomenon will be examined further.
The NOS pathway affects blood vessel formation.
After induction of retinal ischemia by laser ablation injury, C57BL6.gfp chimeras produced a variety of gfp + blood vessels at the sites of injury ranging from small capillaries to larger vessels. In C57BL6.gfp chimeras, size was most likely dictated by the degree of the laser injury (Fig. 2c, e and g ) and no gfp + contribution to vasculature was observed in control eyes ( Fig. 2d and f) .
iNOS.gfp chimeras produced primarily small, highly branched blood vessels that perfused readily in treated eyes ( Fig. 3e and g ). These animals had limited donor EPC contribution in contralateral untreated eyes ( Fig. 3d and f) . Strikingly, eNOS.gfp chimeras only produced relatively large and unbranched vessels regardless of ischemic insult (Fig. 4d through g ). Fig. 3e and g ), but substantially reduced contribution was found in the retinas from the contralateral untreated eye (Fig. 3d and f) .
Unexpectedly, retinas from eNOS -/-recipients, which as described in other studies have systemic vascular dysfunction 21 , demonstrated robust gfp + HSC derived contribution to the preexisting vascular endothelium of both test ( Fig. 4e and g) and control eyes ( Fig. 4d and f) . The profound contribution of HSC derived gfp + cells to the untreated retinas of eNOS -/-recipients strongly suggested that lack of eNOS causes chronic vascular injury and is sufficient to induce hemangioblast activity from the HSC.
ENOS -/-recipients have whole body vascular remodeling by WT HSC/EPC.
To Results for the spleen, thymus and brain are shown (Fig. 5) . In all cases the C57BL6.gfp and iNOS.gfp yielded similar results: few gfp + cells being incorporated into blood vessels in any tissue outside of the treated retina (Fig. 5 a-f, and data not shown). This indicates that in our model whole body irradiation alone and the lack of the iNOS isoform is not sufficient for induction of HSC WT animals showed occasional gfp + , MECA-32 + EC in the brain (closest organ to the site of VEGF administration) with the majority of tissues such as the spleen (Fig. 6 a-d) 
Detection and localization of NOS produced in knockout animals.
Since NOS knockout animals still have functional NOS genes, the pathology observed may be due to a dysregulation or compensatory NO production by the remaining isoforms. To ascertain the influence and determine the expression of NOS in animals lacking one specific NOS isoform, retinas were dissected and stained with NOS isoform specific antibodies from mice which had not undergone HSC transplantation or the neovascularization model. iNOS -/- (Fig. 3 a-c) and eNOS -/- (Fig. 4 a-c) animals were compared for NOS expression in parallel.
Animals were sacrificed and the eyes enucleated. Following staining with NOS isoform specific antibodies and peanut agglutin, retinas were then imaged through fluorescence microscopy. In each figure "panel a" demonstrates that in each knockout strain the isoform which is deleted is not expressed in vivo at This dysregulation may account for the pathologic blood vessel formation observed in these animals.
Discussion
While few topics have stirred more debate recently, the promise of HSC plasticity still holds tremendous potential as cell therapy for many debilitating diseases.
HSC have been shown to transdifferentiate into a variety of non-hematopoietic tissues in various organs such as the vasculature, liver, brain, cardiac muscle, intestine, and pancreas. 2, [22] [23] [24] [25] [26] Nevertheless, attempts to recapitulate these studies have found limited HSC plasticity. 27, 28 Major questions have been raised concerning HSC fusion
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, however the lack of fusion seen in diverse tissues is remarkable and does not appear to be the predominant method of HSC production of EC. 10 Importantly, circulating donor-derived EPC retain normal 2N ploidy in our model. 9 Circulating EPC were initially described in the late part of the last century. 4 We used a novel model of retinal neovascularization in combination with single HSC transplantation to demonstrate that EPC are derived from HSC and represent an alternative developmental fate. 2 The low turnover rate of normal vascular endothelium results in infrequent EC replacement in the absence of injury. The unique physiology of adult retinal vasculature results in new vessels being primarily formed from circulating EPC rather than resident EC proliferation. Therefore, the model was ideally suited for determining the cell of EPC origin to the bone marrow.
In this study we begin the exploration of what dictates EC-versus EPC-driven vascular repair. Clearly in normal ischemia, as observed in the hindlimb model, EC contribute primarily to reperfusion. 13, 14 However in our retina ischemia model we find donor-derived EPC contribute to the majority of neovascularization.
These conflicting observations were resolved through further study of eNOS -/-mice. In these animals the retina vasculature, along with the vasculature of other unrelated organs, was replaced with donor-derived EPC independent of growth factor administration. We conclude that resident eNOS -/-EC are in a state of chronic injury resulting in a competitive disadvantage with respect to WT donorderived EPC. This resulted in widespread WT donor-derived EPC contribution to the vasculature throughout the eNOS -/-recipients. This finding suggests that the NO pathway may be a critical in determining whether EC or EPC contribute to neovascularization. It is very interesting to note that eNOS has recently been implicated in hematopoietic progenitor mobilization from the bone marrow.
13
NOS activity also dictates the general size and branch characteristics of new blood vessels formed in response to ischemic injury. Donor WT HSC transplanted into iNOS -/-recipients (retaining eNOS activity) produce highly branched vessels that are generally smaller in size. These vessels are functional as measured by perfusion of marker dye. In contrast, eNOS -/-recipients produced primarily unbranched vessels of large size in response to injury. This response was in addition to the widespread vascular remodeling by donor HSC seen throughout the eNOS -/-recipients. These vessels were also difficult to perfuse indicative of the general vascular dysfunction described in these knockouts. 21 Note that in figure 4 , E and G are low magnification images allowing visualization of large portions of retina. The abrupt end of vessels in the center occur where the retinal optic disc was separated from the incoming optic nerve/vessel bundle. The ability to dictate the general size and type of vessel formed by HSC/progeny in response to ischemic injury by altering NOS activity may allow specific remodeling of vascular beds with targeted treatment regimes.
Several commonly used pharmaceuticals available affect either specific NOS isoform activity or NO levels. We are currently testing their affects on hemangioblast activity in our model. They may allow for the dissection of the EC to EPC mechanism described, or could potentially provide therapy for vascular defects by dictating vessel branching and functionality.
The role of HSC in production of EPC is not surprising with recent groups demonstrating that a NO defect decreases BM mobilization. 13 Confocal Z-series images were compressed and counted "blindly" for number of vessel branchpoints per image. C57BL/6.gfp retinas averaged 17.8 branches per image (n=5). iNOS.gfp retinas averaged 48 branchpoints per image (n=4). eNOS.gfp retinas averaged 0.29 branchpoints per image (n=38). The blood vessels of iNOS -/-retinas were 2.7 times more branched than WT animals (p< 0.0001) while eNOS -/-were 61.5 times less branched than WT (p< 0.0002).
